← Eichor
Study identifier: NCT03040583 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The ASSESS National Multi-center Prospective Cohort

Condition: Primary Sjögren's Syndrome  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants395
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The ASSESS national multi-center prospective cohort (Assessment of Systemic complications (Signs) and Evolution in Sjögren's Syndrome "SS") was set up in 2006 thanks to a grant of the French Ministry of Health. Fifteen centers for autoimmune diseases consecutively included consecutive patients with Primary Sjögren's Syndrome "pSS" fulfilling American-European Consensus Criteria (AECG) between 2006 and 2009. The study was approved by the Ethics Committee of Bichat Hospital in 2006. All patients gave their informed written consent. This study was followed for 5 years with the grant of the French Ministry of Health and this study will be extended for 20 years by French Society of Rheumatology (SFR). On an annual basis for a duration of 20 years, a thorough standardized paper case report form (CRF) was filled prospectively by clinicians.

This description comes directly from the study's public registry record.

Talk to the study team

Xavier Mariette  ·  01.45.21.37.58  ·  xavier.mariette@aphp.fr

Jacques-Eric Gottenberg  ·  03.88.12.79.50  ·  jacques-Eric.gottenberg@chru-strasbourg.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hopital BicêtreLe Kremlin-Bicêtre, Val De Marne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03040583